Teresa Brophy Bair is Chief Legal Officer of Kura Oncology, Inc.. Currently has a direct ownership of 68,979 shares of KURA, which is worth approximately $1.23 Million. The most recent transaction as insider was on May 20, 2024, when has been sold 2,615 shares (Common Stock) at a price of $22.15 per share, resulting in proceeds of $57,922. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69K
0% 3M change
198.29% 12M change
Total Value Held $1.23 Million

Teresa Brophy Bair Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Open market or private sale
$57,922 $22.15 p/Share
2,615 Reduced 3.65%
68,979 Common Stock
Jan 29 2024
SELL
Open market or private sale
$36,543 $17.8 p/Share
2,053 Reduced 2.89%
68,979 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
46,250 Added 39.43%
71,032 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
23,125 Added 50.0%
23,125 Common Stock
Nov 17 2022
SELL
Open market or private sale
$31,962 $15.22 p/Share
2,100 Reduced 100.0%
0 Common Stock

Also insider at

ATNX
Athenex, Inc. Healthcare
TBB

Teresa Brophy Bair

Chief Legal Officer
San Diego, CA

Track Institutional and Insider Activities on KURA

Follow Kura Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

News

Receive news related to Kura Oncology, Inc.

Track Activities on KURA